The NeuralRad LLC team is tackling minimizing risk and maximizing benefit of radiosurgery by refining the temporal precision and adaptability of treatments ultimatelyto improve survival rates and dramatically enhance the quality of life for cancer patients. At the core of the firm's approach is their judgment that Whole brain radiotherapy should be replaced by stereotactic radiosurgery - enabling better treatment outcome, improved quality of life, improved tumor control and - critical - a longer 5 years survival rate
